A prospective real-world analysis of erenumab in refractory chronic migraine
ConclusionErenumab may be an effective and well tolerated therapy for medically refractory CM patients with and without medication overuse.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Botox | Chronic Pain | Constipation | Disability | Headache | Migraine | Neurology | Pain